
CYTK’s latest rating updates from top analysts.
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.12
Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.12
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.25 million
Cytokinetics Inc’s recent filing unveils that its Director Kaye Edward M. MD unloaded Company’s shares for reported $0.34 million on
Cytokinetics Inc’s recent filing unveils that its Director Kaye Edward M. MD unloaded Company’s shares for reported $0.34 million on
In a filing, Cytokinetics Inc revealed its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $76620.0
Cytokinetics Inc’s recent filing unveils that its President & CEO Blum Robert I unloaded Company’s shares for reported $0.19 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc
Cytokinetics Inc’s recently made public that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $72680.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc